IME Medical Electrospinning is launching the MediSpin XL platform for large-scale industrial manufacturing of reproducible and scalable fiber-based scaffolds for Class I, II, and III medical devices. The platform supports controlled large-scale production of well-defined scaffolds for implants and membranes using fibers ranging from nanometer up to micrometer scale.
Applying specific polymers, IME’s advanced equipment creates fiber-based medical device solutions that mimic the natural human extracellular matrix in nanometer and micrometer format for implants and membranes in the human body. Human cells recognize this artificial matrix (scaffold) as the body’s own facilitating the repair of the damaged tissue for heart valves, blood vessels, nerves, tendons, skin, and bone, etc., the company reported in a news release. This is in contrast to implants and membranes of traditional structures, which are seen as foreign and therefore can lead to scar tissue or rejection phenomena, it explained.
“The global launch of our state-of-the art production platform is testimony to our strong belief in the strategic goal of becoming the leading developer and producer of the most advanced electrospinning equipment for both large-scale production and R&D purpose and broadens our trusted partnership worldwide in co-developing electrospun medical devices, which are seen as true game changers in the MedTech industry,” stated Judith Heikoop, managing director of IME Medical Electrospinning, in a news release.
Added Ramon Solberg, founder and managing director of IME Medical Electrospinning: “This technology enables the large-scale manufacturing of reproducible and scalable fiber-based scaffolds, the wonderful pieces of art that will substantially transform the medical device market for a wide variety of medical applications and thus revolutionize regenerative medicine.”
The MediSpin XL platform has reportedly eliminated all the important factors that might distort the electrospinning process, enabling an optimal process set-up and stability, including climate control and on-line quality monitoring measurements, ensuring a consistent end-product, the company claimed.
[Image courtesy of IME MEDICAL ELECTROSPINNING]
Editor's Note: If you have news you’d like to submit for potential inclusion in future weekly roundups, please send a press release and any related images to email@example.com with the subject line “Supplier Stories.”